related events
Nature: Ursodeoxycholic acid may prevent COVID-19
htmlOn December 5, researchers at the University of Cambridge, UK published a research paper in the journal Nature (Nature) stating that a drug ursodeoxycholic acid (UDCA) that treats liver disease can close the ACE2 receptor, closes the door for viruses to enter cells . This drug can be used to prevent COVID-19 infection. Since this drug targets host cells rather than viruses, it may prevent new future variants of the virus, as well as other coronavirus that may appear.Event Comment
After three years, good news finally came. This research paper published in the international authoritative academic journal "Nature" magazine instantly ignited the A-share market ursodeoxycholic acid concept stock . His research believes that the reason why the new coronavirus can invade the human body is that it is put in a receptor called ACE2 in the cell, and ursodeoxycholic acid can pay attention to this receptor. Ursodeoxycholic acid is not only effective in treatment, but also not afraid of virus mutation. Researchers are optimistic that it may become an important weapon for humans to fight the new coronavirus. At present, the patented drug of ursodeoxycholic acid has passed, which means it can be produced by imitation and is easier for patients to obtain. However, the experimental findings have not been further verified in the clinical stage.
related concept stocks
Tong Pharmaceutical, Haichen Pharmaceutical, Fu'an Pharmaceutical , Guangshengtang, Zhendong Pharmaceutical , Yuheng Pharmaceutical , Qianhong Pharmaceutical , Anlikang, Xinhua Pharmaceutical , Rundu Co., Ltd., etc.
Data source: Oriental Fortune
Tips
Ursodeoxycholic acid is an organic compound, odorless and bitter taste. It is used in medicine to increase bile acid secretion, change bile components, and reduce cholesterol and cholesterol fat in bile. It can be used to treat gallstones , cholestatic liver disease, fatty liver, various types of hepatitis , toxic liver disorders, cholecystitis, bile tractitis, bile indigestion, bile reflux gastritis, etc.
Risk warning: All display information is for reference only and does not constitute any investment advice. Some content and data on this platform are derived from public information or third parties and do not represent the views of Galaxy Securities. Galaxy Securities does not make any guarantee on the accuracy, completeness, reliability and timeliness of information, and is not an invitation or guarantee for the purchase or purchase of Securities or other financial instruments. Investors need to make investment decisions independently and bear the investment risks of alone. Investment is risky, so be cautious when entering the market. Galaxy Securities reminds investors to pay close attention to their own risk tolerance and investment goals.
